Sight Sciences Inc

Company Profile

Sight Sciences Inc had its IPO on 2021-07-15 under the ticker symbol SGHT.

The company operates in the Healthcare sector and Medical Devices industry. Sight Sciences Inc has a staff strength of 250 employees.

Stock update

Shares of Sight Sciences Inc opened at $3.81 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $3.06 - $4.04, and closed at $3.28.

This is a -49.62% slip from the previous day's closing price.

A total volume of 2,872,462 shares were traded at the close of the day’s session.

In the last one week, shares of Sight Sciences Inc have slipped by -49.85%.

Sight Sciences Inc's Key Ratios

Sight Sciences Inc has a market cap of $318.18 million, indicating a price to book ratio of 3.3746 and a price to sales ratio of 9.8107.

In the last 12-months Sight Sciences Inc’s revenue was $81.52 million with a gross profit of $58.97 million and an EBITDA of $-71022000. The EBITDA ratio measures Sight Sciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Sight Sciences Inc’s operating margin was -87.9% while its return on assets stood at -21.02% with a return of equity of -43.28%.

In Q2, Sight Sciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 36.2%.

Sight Sciences Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-1.47 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Sight Sciences Inc’s profitability.

Sight Sciences Inc stock is trading at a EV to sales ratio of 6.386 and a EV to EBITDA ratio of -5.221. Its price to sales ratio in the trailing 12-months stood at 9.8107.

Sight Sciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$185.29 million

Total Liabilities

$14.05 million

Operating Cash Flow

$0

Capital Expenditure

$97000

Dividend Payout Ratio

0%

Sight Sciences Inc ended 2024 with $185.29 million in total assets and $0 in total liabilities. Its intangible assets were valued at $185.29 million while shareholder equity stood at $136.13 million.

Sight Sciences Inc ended 2024 with $0 in deferred long-term liabilities, $14.05 million in other current liabilities, 49000.00 in common stock, $-271064000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $154.52 million and cash and short-term investments were $154.52 million. The company’s total short-term debt was $1,064,000 while long-term debt stood at $33.61 million.

Sight Sciences Inc’s total current assets stands at $182.32 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $18.10 million compared to accounts payable of $2.95 million and inventory worth $7.91 million.

In 2024, Sight Sciences Inc's operating cash flow was $0 while its capital expenditure stood at $97000.

Comparatively, Sight Sciences Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$3.28

52-Week High

$15.295

52-Week Low

$3.06

Analyst Target Price

$10.48

Sight Sciences Inc stock is currently trading at $3.28 per share. It touched a 52-week high of $15.295 and a 52-week low of $15.295. Analysts tracking the stock have a 12-month average target price of $10.48.

Its 50-day moving average was $7.45 and 200-day moving average was $9.65 The short ratio stood at 4.34 indicating a short percent outstanding of 0%.

Around 2155.7% of the company’s stock are held by insiders while 5964.2% are held by institutions.